Managers / Q2 2021 · view latest →
Parkman Healthcare Partners LLC
CIK 0001777015 · 700 CANAL STREET, 2ND FLOOR, STAMFORD, CT, 06902 · 2035163690
Reported Value
$457M
Q2 2021
Positions
82
Filings on Record
26
2019–present window
Filed
Aug 13, 2021
original filing
Summary
Parkman Healthcare Partners Llc reported $457M in U.S.-listed holdings across 82 positions for Q2 2021.
Its largest position, ACRS, represents 5.8% of the portfolio.
Compared with Q1 2021, the fund opened 16 new positions and exited 17.
Reported Value by Quarter
13F Reported Value
Portfolio Composition
By security type
- Common Stock · 91.6% · $419M
- Other · 5.5% · $25M
- ADR · 2.8% · $13M
Quarter-over-Quarter Changes full breakdown →
Holdings — Q2 2021
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $970M | 90 | May 15, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $1.1B | 100 | Feb 17, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $959M | 91 | Nov 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $870M | 88 | Aug 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $843M | 91 | May 15, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $751M | 89 | Feb 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $783M | 93 | Nov 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $747M | 90 | Aug 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $815M | 99 | May 15, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $710M | 89 | Feb 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $546M | 102 | Nov 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $577M | 95 | Aug 11, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $460M | 83 | May 12, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $375.5B | 81 | Feb 13, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $352M | 89 | Nov 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $272M | 76 | Aug 12, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $342M | 80 | May 13, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $453M | 84 | Feb 11, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $395M | 74 | Nov 12, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $457M | 82 | Aug 13, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $431M | 83 | May 14, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $390M | 83 | Feb 12, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $378M | 84 | Nov 13, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $355M | 79 | Aug 13, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $216M | 66 | May 15, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $346M | 69 | Feb 13, 2020 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.